
More than ever, drug makers need to be fleet and flexible-and they need their software to be the same.
Kathleen Martin is a managing consultant for the Life SciencesâPharma-ceuticals team at the IBM Institute for Business Value

More than ever, drug makers need to be fleet and flexible-and they need their software to be the same.

Published: November 1st 2007 | Updated: